Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCOAU
3051
DELISTED
ScION Tech Growth I Unit
SCOAU
| $997K | ﹤0.01% |
100,000
| – | – |
|
|
HERAU
3052
DELISTED
FTAC Hera Acquisition Corp. Units
HERAU
| $996K | ﹤0.01% |
100,000
-100,000
| -50% | -$1M |
|
|
SHQAU
3053
DELISTED
Shelter Acquisition Corporation I Units
SHQAU
| $995K | ﹤0.01% |
100,000
-5,213,000
| -98% | -$52M |
|
|
HCIIU
3054
DELISTED
Hudson Executive Investment Corp. II Unit
HCIIU
| $994K | ﹤0.01% |
100,000
| – | – |
|
|
FRWAU
3055
DELISTED
PWP Forward Acquisition Corp. I Units
FRWAU
| $993K | ﹤0.01% |
100,000
| – | – |
|
3056
Columbia Sportswear
COLM
$3.04B
| $989K | ﹤0.01% |
10,326
-8,771
| -46% | -$885K |
|
|
VGR
3057
DELISTED
Vector Group Ltd.
VGR
| $986K | ﹤0.01% |
109,051
-6,555
| -6% | -$63.9K |
|
3058
Mesa Laboratories
MLAB
$564M
| $984K | ﹤0.01% |
3,254
-566
| -15% | -$161K |
|
|
VBIV
3059
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $981K | ﹤0.01% |
10,514
-19,095
| -64% | -$1.81M |
|
3060
Innoviva
INVA
$1.55B
| $979K | ﹤0.01% |
58,561
+14,708
| +34% | +$220K |
|
|
LHCG
3061
DELISTED
LHC Group LLC
LHCG
| $979K | ﹤0.01% |
6,243
-6,927
| -53% | -$1.3M |
|
3062
Nkarta
NKTX
$150M
| $976K | ﹤0.01% |
35,112
-49,293
| -58% | -$1.56M |
|
3063
OPAL Fuels
OPAL
$71.3M
| $976K | ﹤0.01% |
+100,000
| New | +$976K |
|
3064
Astec Industries
ASTE
$1.16B
| $975K | ﹤0.01% |
18,111
-2,434
| -12% | -$144K |
|
|
CHS
3065
DELISTED
Chicos FAS, Inc.
CHS
| $974K | ﹤0.01% |
216,978
+85,762
| +65% | +$490K |
|
3066
Enova International
ENVA
$6.33B
| $973K | ﹤0.01% |
28,175
-5,578
| -17% | -$182K |
|
3067
CALL
Illumina
ILMN
$31B
| $973K | ﹤0.01% |
+2,467
| New | +$1.13M |
|
3068
Park National Corp
PRK
$3.76B
| $972K | ﹤0.01% |
7,968
-4,445
| -36% | -$518K |
|
3069
PennyMac Financial
PFSI
$3.92B
| $971K | ﹤0.01% |
15,892
-28,756
| -64% | -$1.83M |
|
3070
Rocket Companies
RKT
$36.5B
| $971K | ﹤0.01% |
60,560
-14,772
| -20% | -$258K |
|
3071
Herbalife
HLF
$1.29B
| $970K | ﹤0.01% |
22,882
-10,018
| -30% | -$495K |
|
3072
Honda
HMC
$39.1B
| $970K | ﹤0.01% |
31,592
-107,675
| -77% | -$3.39M |
|
|
MTOR
3073
DELISTED
MERITOR, Inc.
MTOR
| $968K | ﹤0.01% |
45,439
-8,026
| -15% | -$187K |
|
3074
Alaunos Therapeutics
TCRT
$4.59M
| $967K | ﹤0.01% |
3,543
-2,850
| -45% | -$872K |
|
3075
America's Car Mart
CRMT
$26.6M
| $966K | ﹤0.01% |
8,267
-220
| -3% | -$30.3K |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.